Entheon Announces Continuance into British Columbia
Vancouver, British Columbia--(Newsfile Corp. - October 8, 2026) - Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has continued out of the jurisdiction of Canada under the Canada Business Corporations Act into the provincial jurisdiction of British Columbia under the Business Corporations Act (British Columbia) (the "BCBCA"). Shareholders approved the continuance at the Company's an
Biotechnology, Cannabis, Psychedelics, Cannabis Ancillary Service Provider
2026-10-08 6:49 PM EDT | Entheon Biomedical Corp.
Psyched Wellness Announces Secured Term Loan
Toronto, Ontario--(Newsfile Corp. - October 8, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. (together the "Lenders") for an aggregate p
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-10-08 5:15 PM EDT | Psyched Wellness Ltd.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use Disorder Among People with HIV
Toronto, Ontario--(Newsfile Corp. - October 8, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psyche
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-10-08 8:19 AM EDT | Rhelion Life Sciences Corp.
Captiva Verde to Install and Build First Water Stations for the Ritz-Carlton, Amelia Island
Jacksonville, Florida--(Newsfile Corp. - October 1, 2026) - Captiva Verde Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces an agreement to launch the first atmospheric water ("AWG") stations for The Ritz-Carlton, Amelia Island. The terms of the agreement are confidential. The operational effective date is scheduled for October 26 or earlier. The Ritz-Carlton Hotel Company is a wholly-owned subsidiary of Marriott International with approxima
Agriculture, Cannabis, Cannabis Manufacturer
2026-10-01 9:00 AM EDT | Captiva Verde Wellness Corp.
CannabCo's Odourless Cannabis Goes From Headline-Making Innovation to More Than 300 Ontario Retail Locations
Toronto, Ontario--(Newsfile Corp. - October 1, 2026) - CannabCo Pharmaceutical Corp. ("CannabCo" or the "Company") announced today that its Odourless OG product is now stocked, ordered or being onboarded by more than 300 licensed Ontario cannabis retailers, only months after its Ontario launch. What began as a headline-making Canadian cannabis innovation is becoming a commercial reality through retailer adoption, product education and word of mouth. The milestone marks a significa
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-10-01 8:36 AM EDT | Cannabco Pharmaceutical Corp.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Calgary for Phase 2 Trial of Psilocybin-Assisted Therapy for PTSD in Survivors of Intimate Partner Violence
Toronto, Ontario--(Newsfile Corp. - September 29, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsid
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-29 7:53 AM EDT | Rhelion Life Sciences Corp.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Expands Supply Agreement with the University of Chieti-Pescara for PEX010 in the TEMPO Clinical Trial of Psilocybin for Treatment-Resistant Depression in Italy
Toronto, Ontario--(Newsfile Corp. - September 25, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research with
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-25 8:48 AM EDT | Rhelion Life Sciences Corp.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Issued New Canadian Patent, Extending the Broadest Natural Psilocybin Patent Estate
Toronto, Ontario--(Newsfile Corp. - September 22, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion"
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-22 7:33 AM EDT | Rhelion Life Sciences Corp.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Delivers PEX010 to Bruyere Health Research Institute's Phase 3 Trial of Microdose Psilocybin in Palliative Care
Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization adv
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-21 7:49 AM EDT | Rhelion Life Sciences Corp.
Simply Solventless Outlines Path to Planned CCAA Exit, Announces Approval of $1.0 Million in Rebates, Settlement of Vendor Take-Back Debt, Revocation of Management Cease Trade Order, and Extension of Stay of CCAA Proceedings, & Provides Financing Update
Calgary, Alberta--(Newsfile Corp. - September 21, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to announce a series of milestones and events that collectively chart the path towards exiting its previously announced restructuring ("Restructuring") between October 31, 2026, and November 30, 2026. These milestones and events include the approval (and pending receipt) of $1.0 million of government rebates ("Rebates"), the settlement of $
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-09-21 7:05 AM EDT | Simply Solventless Concentrates Ltd.
Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2026) - Vex
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-09-17 4:30 PM EDT | VEXT Science, Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research for PEX010 in a Study of Low and Medium Dose Psilocybin
Toronto, Ontario--(Newsfile Corp. - September 17, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly ow
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-17 7:52 AM EDT | Rhelion Life Sciences Corp.
Nextleaf Announces Leadership Transition and Strategic Review; Sam Kassem Appointed Interim CEO
Vancouver, British Columbia--(Newsfile Corp. - September 15, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf" or the "Company"), an innovation-driven Canadian cannabis processor, announces that Emma Andrews has stepped down as Chief Executive Officer, President and a director of the Company. The Board of Directors has appointed Sam Kassem, the Company's current Chief Financial Officer and a director of the Company, as Interim Chief Executive Officer
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2026-09-15 7:50 PM EDT | Nextleaf Solutions Ltd.
CBD of Denver, Inc. (CBDD) Signs Definitive Share Exchange Agreement with BioCannabis M. IKE, Advancing Strategic Merger Toward Completion
Denver, Colorado--(Newsfile Corp. - September 15, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced that it has entered into a definitive Share Exchange Agreement with BioCannabis M. IKE ("BioCannabis"), a Greece-based company operating in the health and wellness sector. The agreement follows the Letter of Intent previously announced by the parties and the completion of CBDD's due diligence review. Following its review of BioCannabis' business, operatio
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-09-15 9:00 AM EDT | CBD of Denver Inc.
Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the University of Southern California for PEX010 in a Trial for Psilocybin-Assisted Mindfulness Therapy
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to announce that its wholly owned subsidiary, Filament Health Corp. ("Filament"), has entered into a supply and licensing agreement with the University of Southern California, on behalf of its Keck School of Medicine of USC, for t
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-15 7:59 AM EDT | Rhelion Life Sciences Corp.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
Toronto, Ontario--(Newsfile Corp. - September 14, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and re
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-14 7:53 AM EDT | Rhelion Life Sciences Corp.
Beckett's Announces Results of Its 2026 Annual and Special Meeting of Shareholders and the Granting of Stock Options
Ontario and Los Angeles, California--(Newsfile Corp. - September 14, 2026) - Beckett's Inc. (CSE: BKTS) ("Beckett's" or the "Company") announces that all items of business were approved by shareholders at the Company's Annual and Special Meeting of shareholders held on September 10, 2026. All five proposed director nominees were elected by shareholders. Shareholders also voted in favour of the re-appointment of Zeifmans LLP as the Company's auditor for the ensuing
Food / Beverages, Cannabis, Health
2026-09-14 7:00 AM EDT | Becketts Inc.
Entheon Adopts Semi-Annual Reporting
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2026) - Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that it has elected to participate in the Coordinated Blanket Order 51-933 – Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the "Blanket Order"), issued by the Canadian Securities Administrators, and adopts semi-annual financial reporting. This news release is being filed
Biotechnology, Cannabis, Psychedelics, Cannabis Ancillary Service Provider
2026-09-11 6:18 PM EDT | Entheon Biomedical Corp.
Psyched Wellness Announces Secured Term Loan
Toronto, Ontario--(Newsfile Corp. - September 10, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. (together the "Lenders") for an aggregat
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-09-10 4:15 PM EDT | Psyched Wellness Ltd.
Rhelion Life Sciences Announces Filament Health is Planning a Stability Program for IBEX011, Its Naturally Derived Ibogaine Drug Candidate
Toronto, Ontario--(Newsfile Corp. - September 10, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic se
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-10 7:55 AM EDT | Rhelion Life Sciences Corp.